ADIPOQ and metabolic dysfunction-associated steatotic liver disease: A variety of potentially predictive biomarkers have been identified so far [7] (see below); some of these might play an active role in the initiation and progression of CVD and might also be linked to NAFLD, such as adiponectin or interleukin- (IL-) 6 [5].